USA
China-US biopharma player raises $47m Series C
Sirnaomics, a China and US-based biopharmaceutical company specializing in gene therapeutics, has raised $47 million in Series C funding across two tranches.
Everstone hires former UTIMCO executive in New York
Indian and Southeast Asia-focused GP Everstone Group has hired Suneel Kaji, who was most recently part of the private markets team at University of Texas Investment Management (UTIMCO), as a managing director based in New York.
Japan's Astroscale expands Series D by $30m
Astroscale, a Japan-based space technology company focused on debris removal, has announced a $30 million extension to its Series D round, bringing the total raised to $80 million.
Sequoia China, HighLight back biotech player Cullgen
Sequoia Capital China and HighLight Capital have led a $16 million Series A round for Cullgen, a biotech company that develops treatments for cancer by targeting previously “undruggable” cellular proteins.
Coatue leads $25m Series C for China's Kyligence
Coatue Management has led a $25 million Series C round for Chinese big data analytics and cloud services company Kyligence.
Fund focus: Hostplus' diversification drive
Australia's Hostplus partners with Natixis-backed Flexstone Partners for an investment program focused on backing middle-market US managers
Australia's Hostplus establishes US emerging managers program
Australian superannuation fund Hostplus has launched an investment program focused on middle-market US private equity managers with Flexstone Partners, a PE unit of Natixis.
China's Up Fintech trades up after $104m US IPO
Up Fintech, an online brokerage firm focused on global Chinese investors that operates in Asia as Tiger Brokers, gained more than 36% in its first day of trading on NASDAQ after raising $104 million in its IPO.
DNX Ventures launches $300m Japan-US VC fund
DNX Ventures, formerly known as Draper Nexus Ventures, has launched its third Japan-US cross-border VC fund with a target of $300 million.
TPG terminates Bill McGlashan amid US bribery scandal
TPG Capital has terminated Bill McGlashan (pictured), founder of its mid-market investment platform TPG Growth and co-founder of impact investment vehicle The Rise Fund, after he was charged this week for his role in the college bribery scandal in the...
Hony co-leads $700m round for US-based STX
Hony Capital has co-led a $700 million funding round for US film and TV studio STX Entertainment along with TPG Growth, the mid-market investment platform of TPG Capital.
Development finance: The great game
As the US overhauls its development finance institution in response to China’s growing infrastructure investment, the PE industry is preparing for a world in which politics goes hand-in-hand with capital
AirAsia sets up venture capital fund
Malaysia’s AirAsia has launched a venture capital fund in partnership with US-based 500 Startups that will focus on digital Southeast Asian businesses in travel, logistics and financial technology.
China-US tensions: Foggy flashpoints
Rhetoric shaping the debate over China's ambitions to become the prime mover in global technology - and what the US could do in response - reflects the geopolitical significance of the issue. Private equity investors are not immune to its impact
Chinese self-driving truck player TuSimple raises $95m Series D
TuSimple, a China and US-based developer of autonomous driving technology for trucks, has closed its Series D round at $95 million, achieving a pre-money valuation of $1 billion.
Deal focus: From space food to sustainable food
Sustainable Bioproducts left stealth mode to raise a $33 million Series A round as it targets commercialization for an edible protein technology that won early backing from NASA
1955 Capital leads Series A for sustainable foods specialist
1955 Capital, a cross-border PE firm that invests in US and European technologies with application potential in Asia, has led a $33 million Series A round for edible protein developer Sustainable Bioproducts.
Deal focus: Advent sees potential in hybrid CRO
Advent International recognized BioDuro as a company uniquely positioned to leverage growth in pharmaceutical R&D outsourcing in China and the US
LP interview: PennSERS
Bryan Lewis, CIO of Pennsylvania State Employees’ Retirement System, discusses accessing Asia, approaches to co-investment, and paring a bloated PE portfolio into a smaller set of strategic relationships
Apax invests $200m in India, US-based Fractal Analytics
Apax Partners has agreed to pay $200 million for a significant minority stake in India and US-based data analytics provider Fractal Analytics.
Bain buys India, US-based IT solutions player Brillio
Bain Capital Private Equity has agreed to acquire a majority stake in US and India-based enterprise technology services company Brillio at an undisclosed price.
US, China-based Apollomics raises $100m Series B
CMB International Capital, a private equity unit of China Merchants Bank, has led a $100 million Series B round for US and China-based biopharmaceutical developer Apollomics.
SunBridge exits Marketo's Japan JV to Adobe
SunBridge Partners, a US-based VC firm that helps companies access Japan, has exited its position in a Japanese joint venture (JV) with B2B cloud technology provider Marketo to Adobe.
Iron Pillar leads $22m round for India's Vyome Therapeutics
Indian venture capital firm Iron Pillar Capital Management has led a $22 million Series D round for Vyome Therapeutics, a domestic pharmaceuticals developer focused on skin diseases.